Eradication of clonally expanded CD4+ T cells
Eradication of clonally expanded CD4+ T cells
批准号:
10548015
负责人:
JOEL N BLANKSON
金额:
$24.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-13 至 2024-04-30
关键词:
Anti-Retroviral AgentsAntigensCD4 Positive T LymphocytesCarboplatinCell DeathCellsCessation of lifeChemotherapy and/or radiationClinicalClonal ExpansionClone CellsCytomegalovirusDNADefective VirusesDiagnosisExcisionFrequenciesFutureHIVHIV AntigensIn VitroIndividualInflammationLeadMalignant neoplasm of lungMeasuresModelingOperative Surgical ProceduresPaclitaxelPersonsPredispositionProcessProliferatingProvirusesRadiation therapyRegimenResidual stateShockT-LymphocyteTestingVaccinationViral AntigensViral Load resultViral reservoirVirusVirus Integrationantiproliferative agentsantiproliferative drugsantiretroviral therapychemoradiationchemotherapeutic agentdesignimmune activationintegration sitepreventresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Clonal expansion is a process where latently infected CD4+ T cells proliferate in
response to their cognate antigen. It is thought that this process contributes significantly
to the size of the HIV reservoir and therefore disrupting this mechanism could have a
huge impact on the number of latently infected cells. We observed a significant decline
in the number of expanded CD4+ T cell clones in an elite suppressor who received
chemoradiation for lung cancer and we hypothesize that we can recapitulate this in vitro
by stimulating CD4+ T cells with a combination of cognate antigen to induce
proliferation, and either chemotherapeutic or antiproliferative agents that would
selectively kill the dividing antigen-specific CD4+ T cells. If successful, a two-step
process of vaccination of individuals with cognate antigen and short term treatment with
chemotherapeutic or antiproliferative agents may be part of a strategy to reduce the size
of the reservoir.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eradication of clonally expanded CD4+ T cells
-
批准号:10621808
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2022
-
负责人:JOEL N BLANKSON
-
依托单位:
mRNA vaccine responses in PLWH
-
批准号:10402541
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2022
-
负责人:JOEL N BLANKSON
-
依托单位:
mRNA vaccine responses in PLWH
-
批准号:10687989
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2022
-
负责人:JOEL N BLANKSON
-
依托单位:
Optimization of high throughput viral outgrowth assays for the detection of HIV-1 reservoirs
-
批准号:10177855
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2018
-
负责人:JOEL N BLANKSON
-
依托单位:
A mouse viral outgrowth assay for the detection of residual HIV-1 reservoirs
-
批准号:9298573
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2015
-
负责人:JOEL N BLANKSON
-
依托单位:
A mouse viral outgrowth assay for the detection of residual HIV-1 reservoirs
-
批准号:8965588
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2015
-
负责人:JOEL N BLANKSON
-
依托单位:
Phenotypic analysis of latently infected CD4+ T cells.
-
批准号:8713921
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2013
-
负责人:JOEL N BLANKSON
-
依托单位:
Phenotypic analysis of latently infected CD4+ T cells.
-
批准号:8610757
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2013
-
负责人:JOEL N BLANKSON
-
依托单位:
Analysis of HIV-1 in mucosal tissue in elite suppressors
-
批准号:8209611
-
项目类别:
-
资助金额:$23.43万
-
财政年份:2011
-
负责人:JOEL N BLANKSON
-
依托单位:
Analysis of HIV-1 in mucosal tissue in elite suppressors
-
批准号:8333997
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2011
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:8013541
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:7684560
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:8212175
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:7769479
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:8879353
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2008
-
负责人:JOEL N BLANKSON
-
依托单位:
Characterization of HIV excape mutants and T cell responses in elite suppressors
-
批准号:7474853
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2007
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:7110268
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:6450960
-
项目类别:
-
资助金额:$11.53万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:6787316
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:6924043
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: